A Phase 1a/1b Dose Escalation/Expansion Study of TTX-080, an HLA-G Antagonist, as Monotherapy and in Combination with Pembrolizumab or Cetuximab in Patients with Advanced Solid Refractory/Resistant Ma |
Contract |
14,285.00 |
Clinical Trial |
Pavani Chalasani |
Cancer Center Division |
06/2024 |
A Phase 3, Randomized, Placebo-Controlled, Double-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients with C3 Glomerulopathy or Immune-Complex Membranoprolifera |
Contract |
7,475.00 |
Clinical Trial |
Amy Sussman |
Medicine |
06/2024 |
A Prospective Randomized Multicenter Global Study Comparing Pulsed Field Ablation versus Anti-Arrhythmic Drug Therapy as a First Line Treatment for Persistent Atrial Fibrillation |
Contract |
945,649.00 |
Clinical Trial |
Wilber Su |
COM Phx Internal Medicine |
06/2024 |
A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered GLPG3667 in Adult Subject |
Contract |
138,245.92 |
Clinical Trial |
Chian Kwoh |
Medicine |
06/2024 |
AdvanTIG-211: A Randomized, Double-blind, Placebo-controlled, Phase II Study Evaluating the Efficacy and Safety of Ociperlimab (WCD118) Combined With Tislelizumab (VDT482) Plus Chemotherapy Versus Pla |
Contract |
2,600.00 |
Clinical Trial |
Sima Ehsani Chimeh |
Cancer Center Division |
06/2024 |
Anchor Biorepository, Sample Shipping and Handling, and Datafile Generation |
Contract |
310,995.00 |
Other Sponsored Activity |
Monika Schmelz |
Pathology |
06/2024 |
Arizona Geriatrics Workforce Enhancement Program |
Cooperative Agreement |
4,923,639.00 |
Instruction |
Mindy Fain |
Arizona Center on Aging |
06/2024 |
Arizona State Opioid Response - Support Overdose Fatality Review Program |
Contract |
376,376.00 |
Other Sponsored Activity |
Daniel Brooks |
COM Phx Ctr Tox&Pharm Ed&Res |
06/2024 |
Building a Translational Workforce Innovation Network (TWIN) |
Grant |
66,914.00 |
Research |
Taben Hale |
COM Phx Basic Medical Sci |
06/2024 |
Conform Pivotal Study: An Evaluation of the Safety and Effectiveness of the Conformal Left Atrial Appendage Seal (CLAAS) for Left Atrial Appendage Occlusion} |
Contract |
627,275.20 |
Clinical Trial |
Marvin Eng |
COM Phx Internal Medicine |
06/2024 |
Controlled Gradient Release of Biologics: Enhanced Nerve Conduit for Long-Gap Injury Repair (STTR Subcontract) |
Contract |
110,234.00 |
Research |
John Elfar |
Orthopedic Surgery |
06/2024 |
COVID-19 Vaccination Border Region Partnership |
Contract |
176,650.10 |
Other Sponsored Activity |
Sheila Soto |
Public Hlth Prac & Trans Rsch |
06/2024 |
Creatine Kinase in the Natural History of Asthma |
Grant |
402,109.00 |
Research |
Stefano Guerra |
Asthma/Airway Disease Rsch Ctr |
06/2024 |
Delineating Host Response to Central Venous Catheter Associated Candida Albicans Biofilm Infections, and Development of Novel Therapeutics to Combat Drug Resistant Biofilms |
Grant |
29,700.00 |
Research |
Abhijit Date |
Pharmacology and Toxicology |
06/2024 |
Dermal Allograft Augmentation of Large and Massive Rotator Cuff Tears |
Contract |
192,759.00 |
Clinical Trial |
Anup Shah |
COM Phx Orthopedics |
06/2024 |
Development of the AcetaSTAT prototype |
Contract |
41,580.00 |
Research |
Gregory Makar |
COM Phx Emergency Medicine |
06/2024 |
Development of Weather-Based DER Output and Power Outage Prediction Models |
Contract |
79,700.00 |
Research |
Chris Chaeha Lim |
Community Environment & Policy |
06/2024 |
Empowering Communities: Amplifying the Reach of the Stock Inhaler for Schools Program in Rural Counties and Tribal Nations through Strategic Partnerships |
Grant |
380,000.00 |
Other Sponsored Activity |
Ashley Lowe |
Asthma/Airway Disease Rsch Ctr |
06/2024 |
Evaluation of Processes Around Injection, Migration, and Long-Term Efficacy of Sponsor?s Wireless Stimulating Device |
Contract |
29,558.02 |
Research |
Andrew Fuglevand |
Physiology |
06/2024 |
Evolution-guided Analysis of Extracellular and Intracellular Mechanisms Driving T Cell Activation |
Grant |
3,271,945.00 |
Research |
Michael Kuhns |
Immunobiology |
06/2024 |